NextCure, Inc.

NXTC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$9-$27-$11-$12
Dep. & Amort.$1$0$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$2
Change in WC$1$3-$4$3
Other Non-Cash$0$0-$0-$0
Operating Cash Flow-$6-$23-$13-$7
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$13-$14-$8
Inv. Sales/Matur.$9$16$21$15
Other Inv. Act.$0$0$0$0
Investing Cash Flow$9$4$7$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$2$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$2$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$17-$6$0
Supplemental Information
Beg. Cash$5$22$28$28
End Cash$7$5$22$28
Free Cash Flow-$6-$23-$13-$7
NextCure, Inc. (NXTC) Financial Statements & Key Stats | AlphaPilot